These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11989385)

  • 1. Reconsidering HRT.
    Cowley G; Springen K
    Newsweek; 2002 Apr; 139(17):71. PubMed ID: 11989385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P
    Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract]   [Full Text] [Related]  

  • 3. Termination of the oestrogen-alone arm of the Women's Health Initiative.
    Stevenson J; Rees M; Marsden J
    J Br Menopause Soc; 2004 Jun; 10(2):47, 59. PubMed ID: 15759323
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of medroxyprogesterone acetate on estrogen-dependent risks and benefits--an attempt to interpret the Women's Health Initiative results.
    Kuhl H; Stevenson J
    Gynecol Endocrinol; 2006 Jun; 22(6):303-17. PubMed ID: 16785155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Women's Health Initiative: not over yet. The largest study of women's health has raised at least as many questions as it has answered. Stay tuned.
    Harv Womens Health Watch; 2006 May; 13(9):1-4. PubMed ID: 16696133
    [No Abstract]   [Full Text] [Related]  

  • 6. Be careful of what you wish for: putting the WHI Estrogen/Progestin and HERS II Trials in perspective.
    Randolph JF;
    Medscape Womens Health; 2002; 7(4):7. PubMed ID: 12466739
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of combination hormone replacement therapy in light of recent data from the Women's Health Initiative.
    Kaunitz AM;
    Medscape Womens Health; 2002; 7(4):8. PubMed ID: 12466740
    [No Abstract]   [Full Text] [Related]  

  • 8. Postmenopausal hormone replacement therapy and the prevention of cardiovascular disease: a review.
    Abramson BL
    J Cardiovasc Risk; 2002 Dec; 9(6):309-14. PubMed ID: 12478199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HRT: forever or never?
    Corson SL
    Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmenopausal hormone therapy: have HERS2 and WHI given us any new information?
    Fylstra DL
    J S C Med Assoc; 2002 Dec; 98(8):299-304. PubMed ID: 12532655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
    Hendrix SL
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
    [No Abstract]   [Full Text] [Related]  

  • 12. Hormone in the hot seat.
    Mandavilli A
    Nat Med; 2006 Jan; 12(1):8-9. PubMed ID: 16397539
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
    Aubuchon M; Santoro N
    Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease.
    Prentice RL; Langer RD; Stefanick ML; Howard BV; Pettinger M; Anderson GL; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2006 Apr; 163(7):589-99. PubMed ID: 16484450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy: need for reappraisal.
    Nath J
    Natl Med J India; 2002; 15(6):346-8. PubMed ID: 12540069
    [No Abstract]   [Full Text] [Related]  

  • 17. Good science or good marketing?
    Head K
    Altern Med Rev; 2002 Aug; 7(4):274-5. PubMed ID: 12197780
    [No Abstract]   [Full Text] [Related]  

  • 18. The menopausal transition: how does route of delivery affect the risk/benefit ratio of hormone therapy?
    Shulman LP
    J Fam Pract; 2004 Jul; Suppl():S13-7. PubMed ID: 15251108
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone therapy. An update on risks and benefits.
    Mayo Clin Womens Healthsource; 2009 Mar; Suppl():1-8. PubMed ID: 19405167
    [No Abstract]   [Full Text] [Related]  

  • 20. Women's health. The vanishing promises of hormone replacement.
    Enserink M
    Science; 2002 Jul; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.